Pasquale Palumbo

Pasquale Palumbo is a prominent neurologist and the president of the Italian Society of Hospital Neurosciences. He serves as the director of Neurology at the Hospital of Prato and leads the Medical Specialties Department at the Tuscan Health Authority. Recently, he was in the news discussing the new monoclonal antibody treatment for early-stage Alzheimer's disease, known as lecanemab, which has received approval from the European Commission, highlighting the conditions under which patients can benefit from this innovative therapy.